NPPB and cardiac hypertrophy: By acting on the RASS and the NPs, sacubitril/valsartan can reduce the secretion of aldosterone, sympathetic nerve activity, cardiac hypertrophy and myocardial fibrosis, and the degradation of NT-proBNP [17, 18, 32].